首页> 外国专利> RECEPTOR-TARGETED NANOPARTICLES FOR ENHANCED TRANSCYTOSIS MEDIATED DRUG DELIVERY

RECEPTOR-TARGETED NANOPARTICLES FOR ENHANCED TRANSCYTOSIS MEDIATED DRUG DELIVERY

机译:受体靶向的纳米颗粒,可增强经转运介导的药物输送

摘要

Receptor-targeted nanoparticles (R-NPs) are provided for selective transport into and through targeted tissues of therapeutic, prophylactic and diagnostic agents. R-NPs can include polymeric particle, lipid particles, inorganic particles, or a combination thereof with a targeting moiety selective for binding to a receptor on the cells where the agent is to be delivered, where the receptor mediates transcytosis of the nanoparticle into and through the cells. In a preferred embodiment, the targeting moiety is the neonatal Fc receptor. Examples demonstrate Fc-targeted nanoparticles which are actively transported across the intestinal epithelium, providing a route for the oral delivery of nanoparticle encapsulated active agents including peptides such as insulin.
机译:提供了靶向受体的纳米颗粒(R-NPs),用于选择性转运进治疗剂,预防剂和诊断剂的目标组织中并通过目标组织。 R-NP可以包括聚合物颗粒,脂质颗粒,无机颗粒或其具有靶向部分的组合,所述靶向部分选择性地结合至要递送药剂的细胞上的受体,其中受体介导纳米颗粒进入和通过细胞的胞吞作用。细胞。在一个优选的实施方案中,靶向部分是新生儿Fc受体。实施例证明了靶向Fc的纳米颗粒可以主动地穿过肠上皮,为口服递送纳米肽包封的活性剂(包括肽,如胰岛素)提供了途径。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号